Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema

European Respiratory Journal

Volumn 9, Issue 9, 1996, Pages 1858-1867

  Schutte H ^a   Lohmeyer, J ^a   Rosseau, S ^a   Ziegler, S ^a   Siebert, C ^a   Kielisch, H ^a   Pralle, H ^a   Grimminger, F ^a   Morr, H ^a   Seeger, W ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Acute respiratory distress syndrome; Bronchoalveolar lavage; Interleukin 5; Interleukin 8; Tumour necrosis factor

Indexed keywords

CYTOKINE; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; LUNG EDEMA; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL;

EID: 9544225041     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.96.09091858     Document Type: Article

References (47)

1. Chollet-Martin S, Montravers P, Gibert C, et al. High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome. Infect Immun 1993; 61: 4553-4559.
2. Donnelly SC, Strieter RM, Kunkel SL, et al. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 1993; 341: 643-647.
3. Miller EJ, Cohen AB, Nagao S, et al. Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 1992; 148: 427-432.
4. Torre D, Zeroli C, Giola M, et al. Levels of interleukin-8 in patients with adult respiratory distress syndrome. J Infect Dis 1993; 167: 505-506.
5. Friedland JS, Supputtamongkol Y, Remick DG, et al. Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomans pseudomallei infection. Infect Immun 1992; 60: 2402-2408.
6. Hack CE, Hart M, Strack van Schijndel RJM, et al. Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun 1992; 60: 2835-2842.
7. Marty C, Misset B, Tamion F, et al. Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit Care Med 1994; 22: 673.
8. Kelley J. Cytokines of the lung. Am Rev Respir Dis 1990; 141: 765-788.
9. Manogue KR, van Deventer SJH, Cerami A. Tumor necrosis factor-alpha or cachectin. The Cytokine Handbook. Chap. 12. New York, Academic Press Ltd, 1991; pp. 241-256.
10. Cannon JG, Tompkins RG, Gelfand JA, et al. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis 1990; 161: 79-84.
11. Cerami A, Beutler B. The role of cachectin/TNF in endotoxic shock and cachexia. Immunol Today 1988; 9: 28-31.
12. van Deventer SJH, Büller HR, ten Cate JW, et al. Experimental endotoxemia in humans: analysis of cytokine release and coagulation fibrinolytic, and complement pathways. Blood 1990; 76: 2520-2526.
13. Tracey KJ, Fong Y, Hesse DC, et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987; 330: 662-664.
14. Leeper-Woodford SK, Carey PD, Byrne K, et al. Tumor necrosis factor - alpha and beta subtypes appear in circulation during onset of sepsis-induced lung injury. Am Rev Respir Dis 1991; 143: 1076-1082.
15. Tracey KJ, Beutler B, Lowry SF, et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234: 470-474.
16. Debets JMH, Kampneijer R, van der Linden MPMH, et al. Plasma tumor necrosis factor and mortality in critically ill septic patients. Crit Care Med 1989; 17: 489-494.
17. Dofferhoff ASM, Bom VJJ, de Vries-Hospers HG, et al. Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans. Crit Care Med 1992; 20: 185-192.
18. Donnelly TJ, Meade P, Jagels M, et al. Cytokine, complement and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury. Crit Care Med 1994; 22: 768-776.
19. Hyers TM, Tricomi SM, Dettenmeyer PA, et al. Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1991; 144: 266-271.
20. Millar AB, Fowley NM, Singer M, et al. Tumor necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet 1989; 23: 712-714.
21. Parsons PE, Moore FA, Moore EE, et al. Studies on the role of tumor necrosis factor in adult respiratory distress syndrome. Am Rev Respir Dis 1992; 146: 694-700.
22. Pinsky MR, Vincent J-L, Deviere J, et al. Serum cytokine levels in human septic shock: relation to multiple-system organ failure and mortality. Chest 1993; 103: 565-575.
23. Roten R, Markert M, Feihl F, et al. Plasma levels of tumor necrosis factor in the adult respiratory distress syndrome. Am Rev Respir Dis 1991; 43: 590-592.
24. Suter PM, Suter S, Girardin E, et al. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon and elastase, in patients with adult respiratory distress syndrome after trauma, shock or sepsis. Am Rev Respir Dis 1992; 145: 1016-1022.
25. Hack CE, De Groot ER, Felt-Bersma JF, et al. Increased plasma levels of interleukin-6 in sepsis. Blood 1989; 74: 1704-1710.
26. Waage A, Brandtzaeg P, Halstensen A, et al. The complex pattern of cytokines in serum from patients with meningococcal septic shock. J Exp Med 1989; 169: 333-338.
27. Grigg JM, Barber A, Silverman M. Increased levels of bronchoalveolar lavage fluid interleukin-6 in preterm ventilated infants after prolonged rupture of membranes. Am Rev Respir Dis 1992; 145: 782-786.
28. Humbert M, Delattre RM, Fattal S, et al. In situ production of interleukin-6 within human lung allografts displaying rejection or cytomegalovirus pneumonia. Transplantation 1993; 56: 623-627.
29. Lindsey HJ, Kisala JM, Ayala A, et al. Pentoxifylline attenuates oxygen-induced lung injury. J Surg Res 1994; 56: 543-548.
30. Trentin L, Garbisa S, Zambello R, et al. Spontaneous production of interleukin-6 by alveolar macrophages from human immunodeficiency virus type-1-infected patients. J Infect Dis 1992; 166: 731.
31. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Am J Respir Crit Care Med 1994; 149: 818-824.
32. Fraser RG (Ed), Paré JAP, Paré PD, et al. Diagnosis of diseases of the chest. 3rd edn. Philadelphia, W.B. Saunders Co., 1989.
33. Rennard SI, Basset G, Lecossier D, et al. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol 1986; 60: 532-538.
34. Espevik T, Nissen-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Meth 1986; 95: 99.
35. Sloane PJ, Gee MH, Gottlieb JE, et al. A multicenter registry of patients with acute respiratory distress syndrome. Am Rev Respir Dis 1992; 146: 419-426.
36. Campbell GD, Coalson JJ, Johanson WG. The effect of bacterial superinfection on lung function after diffuse alveolar damage. Am Rev Respir Dis 1984; 129: 974-978.
37. Hyers TM, Fowler AA. Adult respiratory distress syndrome: causes, morbidity and mortality. Fed Proc 1986; 45: 25-29.
38. Seidenfeld JJ, Pohl DF, Bell RC, et al. Incidence, site and outcome of infections in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1986; 134: 12-16.
39. Jorens PG, Van Damme J, De Backer W, et al. Interleukin 8 (IL-8) in the bronchoalveolar lavage fluid from patients with the adult respiratory distress syndrome (ARDS) and patients at risk for ARDS. Cytokine 1992; 4: 592-597.
40. Kunkel SL, Standiford T, Kasahara K, et al. Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Exp Lung Res 1991; 17: 17-23.
41. Van Damme J. Interleukin-8 and related molecules. In: Thomson AW, ed. The Cytokine Handbook: Immunology and Molecular Biology of Cytokines. New York, Academic Press, 1991; pp. 201-214.
42. Van Zee KJ, DeForge LE, Fischer E, et al. IL-8 in septic shock, endotoxemia, and after IL-1 administration. J Immunol 1991; 146: 3478-3482.
43. Walmrath D, Ghofrani AH, Rosseau S, et al. Endotoxin "priming" potentiates lung responsiveness to E. coli hemolysin: an example of endo- and exotoxin co-operativity. J Exp Med 1994; 180: 1437-1443.
44. Walmrath D, Griebner M, Kolb B, et al. Endotoxin primes perfused rabbit lungs for enhanced vasoconstrictor response to staphylococcal α-toxin. Am Rev Respir Dis 1993; 148: 1179-1186.
45. Blick M, Sherwin SA, Rosenblum M, et al. Phase I study of recombinant tumor necrosis factor in cancer patients. Cancer Res 1987; 47: 2986-2989.
46. Chollet-Martin S, Montravers P, Gibert C, et al. Sub-population of hyperresponsive polymorphonuclear neutrophils in patients with adult respiratory distress syndrome. Am Rev Respir Dis 1992; 146: 990-996.
47. Meduri GU, Headley S, Kohler G, et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Chest 1995; 107: 1062-1173.